GB1507521A - Dosage unit - Google Patents
Dosage unitInfo
- Publication number
- GB1507521A GB1507521A GB10214/75A GB1021475A GB1507521A GB 1507521 A GB1507521 A GB 1507521A GB 10214/75 A GB10214/75 A GB 10214/75A GB 1021475 A GB1021475 A GB 1021475A GB 1507521 A GB1507521 A GB 1507521A
- Authority
- GB
- United Kingdom
- Prior art keywords
- active ingredient
- coat
- sugar
- cellulose
- dosage units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2767374A JPS5512411B2 (US07714131-20100511-C00038.png) | 1974-03-12 | 1974-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1507521A true GB1507521A (en) | 1978-04-19 |
Family
ID=12227459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB10214/75A Expired GB1507521A (en) | 1974-03-12 | 1975-03-12 | Dosage unit |
Country Status (12)
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0106202A2 (en) * | 1982-09-20 | 1984-04-25 | Fujisawa Pharmaceutical Co., Ltd. | Soft capsule |
US6284271B1 (en) | 1997-07-01 | 2001-09-04 | Astrazeneca Ab | Multiple unit effervescent dosage form |
WO2023166225A1 (en) * | 2022-03-04 | 2023-09-07 | APET Holding B.V. | Digestive enzyme formulations |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
US4207890A (en) * | 1977-01-04 | 1980-06-17 | Mcneilab, Inc. | Drug-dispensing device and method |
JPS6024767B2 (ja) * | 1979-08-24 | 1985-06-14 | 塩野義製薬株式会社 | 腸溶性硬カプセル剤 |
JPS58501128A (ja) * | 1981-07-15 | 1983-07-14 | キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド | 徐放性テオフイリン |
US4451260A (en) * | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
JPS59193831A (ja) * | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
JPS61107782U (US07714131-20100511-C00038.png) * | 1984-12-19 | 1986-07-08 | ||
US4735804A (en) * | 1985-05-10 | 1988-04-05 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4758436A (en) * | 1985-05-29 | 1988-07-19 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4666705A (en) * | 1985-06-03 | 1987-05-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
DE3803482A1 (de) * | 1988-02-05 | 1989-08-17 | Lohmann Therapie Syst Lts | Schwimmfaehiges orales therapeutisches system |
JPH082781B2 (ja) * | 1988-10-18 | 1996-01-17 | 嘉明 川島 | 中空顆粒状医薬及びその製法 |
EP0536277A1 (en) * | 1990-06-25 | 1993-04-14 | The Du Pont Merck Pharmaceutical Company | Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5198229A (en) * | 1991-06-05 | 1993-03-30 | Alza Corporation | Self-retaining gastrointestinal delivery device |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
JP2671257B2 (ja) * | 1995-07-13 | 1997-10-29 | エーザイ株式会社 | 溶解遅延性ゼラチン製剤組成物 |
IN186245B (US07714131-20100511-C00038.png) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
KR100620935B1 (ko) | 1998-03-19 | 2006-09-13 | 브리스톨-마이어스스퀴브컴파니 | 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법 |
EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
US20030203027A1 (en) * | 2002-04-26 | 2003-10-30 | Ethicon, Inc. | Coating technique for deposition of drug substance on a substrate |
US20040086566A1 (en) * | 2002-11-04 | 2004-05-06 | Alpharma, Inc. | Waxy matrix dosage forms |
US7485322B2 (en) * | 2002-12-24 | 2009-02-03 | Lek Pharmaceuticals D.D. | Modified release pharmaceutical composition |
EP1596841B1 (en) * | 2003-02-21 | 2008-10-08 | LEK Pharmaceuticals D.D. | Therapeutic system comprising amoxicillin and clavulanic acid |
JP2007510654A (ja) * | 2003-11-04 | 2007-04-26 | スパーナス ファーマシューティカルズ インコーポレイテッド | 分極した酸素原子を有するポリマーを含むマトリクスからの正に荷電した薬理学的活性分子の徐放 |
EP2068844A4 (en) * | 2006-09-04 | 2013-01-23 | Panacea Biotec Ltd | PROGRAMMABLE RELEASE TECHNIQUE BY FLOATING SYSTEM |
WO2009087665A2 (en) * | 2007-12-11 | 2009-07-16 | Vishwanath Sudhir Nande | Novel gastroretentive drug delivery system |
GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
EP2329810A4 (en) * | 2008-08-18 | 2012-09-19 | Team Academy Of Pharmaceutical Science | DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION |
FR2945947B1 (fr) | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Compositions pharmaceutiques flottantes a liberation controlee |
FR2945945B1 (fr) * | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Procede de preparation de particules creuses et leurs applications |
JP5594484B2 (ja) * | 2009-07-06 | 2014-09-24 | 杏林製薬株式会社 | 中空構造を有する錠剤 |
CA2803064C (en) * | 2010-07-05 | 2017-12-19 | Jagotec Ag | Dosage form |
EP2731609A1 (en) * | 2011-07-14 | 2014-05-21 | APeT Holding B.V. | Nicotinamide compositions and the therapeutic use thereof |
CA2851765C (en) | 2011-10-11 | 2017-08-15 | Ranbaxy Laboratories Limited | A gastroretentive dosage system and process of preparation thereof |
MX2015000760A (es) * | 2012-07-16 | 2015-09-10 | Apet Holding B V | Sistema de suministro de farmaco gastro - retentivo. |
RS54024B1 (en) | 2012-10-12 | 2015-10-30 | Omya International Ag | GASTRORETENCY FORMULATION OF MEDICINES AND SYSTEMS FOR DELIVERY AND METHODS OF THEIR PREPARATION USING FUNCTIONALIZED CALCIUM CARBONATE |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
KR20220162852A (ko) | 2014-06-11 | 2022-12-08 | 메사추세츠 인스티튜트 오브 테크놀로지 | 체류 구조체 및 관련 방법 |
EP3034070A1 (en) | 2014-12-18 | 2016-06-22 | Omya International AG | Method for the production of a pharmaceutical delivery system |
EP3069713A1 (en) | 2015-03-20 | 2016-09-21 | Omya International AG | Dispersible dosage form |
CN104706613B (zh) * | 2015-03-20 | 2018-01-16 | 华侨大学 | 一种胃漂浮空心缓释片的制备方法 |
WO2016178971A1 (en) | 2015-05-01 | 2016-11-10 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
CN108472249A (zh) | 2015-10-23 | 2018-08-31 | 林德拉有限公司 | 用于治疗剂缓释的胃驻留系统及其使用方法 |
MX2018006912A (es) | 2015-12-08 | 2018-08-16 | Lyndra Inc | Configuracion geometricas para sistemas de residencia gastrica. |
EP3429556A1 (en) * | 2016-03-18 | 2019-01-23 | Grünenthal GmbH | Floating pharmaceutical dosage form |
EP3269361A1 (en) | 2016-07-14 | 2018-01-17 | Omya International AG | Dosage form |
CA3038557A1 (en) | 2016-09-30 | 2018-04-05 | Lyndra, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
WO2021176361A1 (en) * | 2020-03-02 | 2021-09-10 | Craft Health Pte Ltd | Method of manufacturing oral dosage forms for extended drug release |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3418999A (en) * | 1964-02-12 | 1968-12-31 | Donald W. Davis | Method of swallowing a pill |
FR1454013A (fr) * | 1965-08-18 | 1966-07-22 | Pluripharm | Mode de présentation de deux médicaments associés |
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
-
1974
- 1974-03-12 JP JP2767374A patent/JPS5512411B2/ja not_active Expired
-
1975
- 1975-03-10 BE BE154189A patent/BE826498A/xx not_active IP Right Cessation
- 1975-03-10 FR FR7507336A patent/FR2263744B1/fr not_active Expired
- 1975-03-11 SE SE7502725A patent/SE409286B/xx not_active IP Right Cessation
- 1975-03-11 DE DE2510620A patent/DE2510620C2/de not_active Expired
- 1975-03-11 US US05/557,408 patent/US3976764A/en not_active Expired - Lifetime
- 1975-03-11 ES ES435500A patent/ES435500A1/es not_active Expired
- 1975-03-11 DK DK97875AA patent/DK142802B/da not_active IP Right Cessation
- 1975-03-12 CA CA221,903A patent/CA1054056A/en not_active Expired
- 1975-03-12 CH CH315475A patent/CH604719A5/xx not_active IP Right Cessation
- 1975-03-12 GB GB10214/75A patent/GB1507521A/en not_active Expired
- 1975-03-12 NL NL7502952A patent/NL7502952A/xx not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0106202A2 (en) * | 1982-09-20 | 1984-04-25 | Fujisawa Pharmaceutical Co., Ltd. | Soft capsule |
EP0106202A3 (en) * | 1982-09-20 | 1985-05-02 | Fujisawa Pharmaceutical Co., Ltd. | New type soft capsule |
US6284271B1 (en) | 1997-07-01 | 2001-09-04 | Astrazeneca Ab | Multiple unit effervescent dosage form |
WO2023166225A1 (en) * | 2022-03-04 | 2023-09-07 | APET Holding B.V. | Digestive enzyme formulations |
Also Published As
Publication number | Publication date |
---|---|
FR2263744A1 (US07714131-20100511-C00038.png) | 1975-10-10 |
DE2510620A1 (de) | 1975-09-18 |
DK142802B (da) | 1981-02-02 |
SE409286B (sv) | 1979-08-13 |
CH604719A5 (US07714131-20100511-C00038.png) | 1978-09-15 |
US3976764A (en) | 1976-08-24 |
SE7502725L (US07714131-20100511-C00038.png) | 1975-09-15 |
JPS50121418A (US07714131-20100511-C00038.png) | 1975-09-23 |
DE2510620C2 (de) | 1984-01-05 |
FR2263744B1 (US07714131-20100511-C00038.png) | 1978-11-24 |
CA1054056A (en) | 1979-05-08 |
BE826498A (fr) | 1975-06-30 |
DK142802C (US07714131-20100511-C00038.png) | 1981-09-21 |
ES435500A1 (es) | 1977-02-01 |
JPS5512411B2 (US07714131-20100511-C00038.png) | 1980-04-02 |
NL7502952A (nl) | 1975-09-16 |
DK97875A (US07714131-20100511-C00038.png) | 1975-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1507521A (en) | Dosage unit | |
TW420616B (en) | Controlled-release dosage forms of azithromycin | |
KR910004578B1 (ko) | 위내 체류형 과립의 제조방법 | |
IE45578L (en) | Propranolol capsules | |
KR880002673B1 (ko) | 진통 캡슐제와 그 제조방법 | |
GB1161439A (en) | Pharmaceutical Compositions | |
JPS5959633A (ja) | 放出調整複合単位組成物の製法 | |
EP0014253A2 (en) | Simethicone antacid tablet | |
CA2132012A1 (en) | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms | |
GB2101485A (en) | Delayed-release pharmaceutical compositions of bromhexine | |
KR870002832A (ko) | 제약 조성물 | |
JPH0772130B2 (ja) | 持続性製剤 | |
JPH029815A (ja) | 改良されたコアー膜付着性質を有する医薬的に許容される活性剤を含む浸透性連続分散性経口投与システム | |
ES388698A1 (es) | Procedimiento para la preparacion de pequenas bolitas medi-camentosas para administracion oral con un revestimiento re-tardador de la liberacion de sustancia activa. | |
KR890009377A (ko) | 방출 조절된 카비도파/레보도파 배합물 | |
KR860001591A (ko) | 펠렛 제제물 및 그의 제조방법 | |
CA2183862A1 (en) | Stabilized composition for oral administration of peptides | |
GB2176704A (en) | Solid, stable dosage forms with an elastic film coating | |
DE3680866D1 (de) | Herstellungsverfahren fuer arzneimittel mit verzoegerter wirkstoffabgabe. | |
FI864207A (fi) | Kontrollerad frigivning av kaliumklorid. | |
JPH02504145A (ja) | 酵素制御薬物放出性ペレット | |
JPH02164821A (ja) | 新規な投与形態 | |
EP0425699A1 (en) | Oral preparation which can be released at suitable region in intestine | |
JPH0260643B2 (US07714131-20100511-C00038.png) | ||
GB888038A (en) | Medicinal tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930312 |